alli (Orlistat 60 mg)
Peripherally acting anti-obesity agent for weight loss in overweight adults
Quick Facts About alli
Key Takeaways
- alli (orlistat 60 mg) blocks about 25% of dietary fat from being absorbed, helping you lose up to 50% more weight than dieting alone.
- Must be taken with a reduced-calorie, low-fat diet; each meal should contain no more than about 15-19 g of fat depending on your daily calorie goal.
- Take a daily multivitamin (vitamins A, D, E, K) at bedtime to compensate for reduced fat-soluble vitamin absorption.
- Do not use alli for more than 6 months; if no weight loss after 12 weeks, consult a healthcare provider.
- Common side effects are gastrointestinal (oily stools, flatulence) and can be managed by sticking to a low-fat diet.
What Is alli and What Is It Used For?
Quick Answer: alli is an over-the-counter weight loss medicine containing orlistat 60 mg. It works by preventing about one quarter of the fat you eat from being absorbed, and is designed for overweight adults with a BMI of 28 or more, used alongside a low-fat, calorie-reduced diet.
alli capsules contain orlistat, a peripherally acting anti-obesity agent that specifically targets fat in the digestive system. Unlike many weight loss supplements that claim to boost metabolism or suppress appetite, orlistat has a well-documented pharmacological mechanism: it inhibits gastrointestinal lipase enzymes, which are responsible for breaking down dietary triglycerides into absorbable fatty acids and monoglycerides. By inactivating these enzymes, approximately 25% of the fat consumed in a meal passes through the gut undigested and is excreted in the stool.
The medication is indicated for weight loss in adults aged 18 years and older who are overweight, defined as having a body mass index (BMI) of 28 or more. BMI is calculated by dividing your weight in kilograms by your height in metres squared. For example, a person who is 170 cm tall would need to weigh at least 81 kg to meet the BMI threshold for alli use. alli is not intended for people who are already at a healthy weight or who are only slightly above normal BMI.
Clinical trials have demonstrated that orlistat, when combined with a reduced-calorie diet, produces significantly greater weight loss than diet alone. The landmark XENDOS (XENical in the prevention of Diabetes in Obese Subjects) trial, a four-year randomised controlled study published in Diabetes Care, showed that orlistat combined with lifestyle modification reduced the incidence of type 2 diabetes by 37% in obese participants. For every 2 kg lost through dietary changes alone, alli can help users lose approximately 1 additional kilogram.
The Health Risks of Being Overweight
Carrying excess weight significantly increases the risk of developing serious health conditions, many of which may not produce noticeable symptoms until they are advanced. These conditions include type 2 diabetes, cardiovascular disease (including coronary artery disease and stroke), hypertension, certain types of cancer (particularly colorectal, breast, and endometrial cancers), osteoarthritis, obstructive sleep apnoea, and non-alcoholic fatty liver disease. Even a modest weight loss of 5-10% of initial body weight has been shown to meaningfully reduce these risks, improve blood lipid profiles, and lower blood pressure according to guidelines from the National Institute for Health and Care Excellence (NICE) and the World Health Organization (WHO).
How alli Works in Your Body
When you eat a meal containing fat, your body releases lipase enzymes from the stomach and pancreas to break down triglycerides into smaller components that can be absorbed through the intestinal wall. Orlistat forms a covalent bond with the active serine residue on these lipase enzymes, permanently inactivating them. The inactivated enzymes can no longer hydrolyse dietary fat, so the intact triglycerides cannot be absorbed and are passed through the digestive tract.
This mechanism is entirely local to the gastrointestinal tract — orlistat has minimal systemic absorption, meaning it does not enter the bloodstream in significant quantities and does not affect the brain, heart, or other organs. This localized action is a key safety advantage compared to centrally acting weight loss agents. However, because undigested fat passes through the intestine, eating high-fat meals while taking alli can lead to gastrointestinal side effects such as oily stools and flatulence, which is why a low-fat diet is essential.
What Should You Know Before Taking alli?
Quick Answer: Do not take alli if you are pregnant or breastfeeding, taking ciclosporin or warfarin, have cholestasis, or have chronic malabsorption syndrome. Consult your doctor if you have diabetes, kidney disease, or take thyroid medications, epilepsy drugs, or HIV medications.
Contraindications
Certain conditions and circumstances make alli unsuitable. You must not take alli in any of the following situations:
- Allergy to orlistat or any other ingredient in the capsules (see What Does alli Contain for a full list of excipients).
- Pregnancy or breastfeeding — weight loss during pregnancy can harm the developing foetus, and it is unknown whether orlistat passes into breast milk.
- Ciclosporin use — orlistat can reduce ciclosporin blood levels, potentially leading to transplant rejection or treatment failure in severe autoimmune conditions.
- Warfarin or other anticoagulants — orlistat may affect vitamin K absorption, altering the effectiveness of blood-thinning medications and increasing bleeding risk.
- Cholestasis — a condition where bile flow from the liver is blocked, which would impair the drug's mechanism of action.
- Chronic malabsorption syndrome — if your body already has difficulty absorbing nutrients, taking a fat-blocking agent could worsen nutritional deficiencies.
Warnings and Precautions
Even if none of the absolute contraindications apply, you should speak with a healthcare provider before starting alli in the following circumstances:
- Diabetes: Weight loss can affect blood sugar levels. Your doctor may need to adjust your diabetes medication (insulin or oral hypoglycaemics) as you lose weight.
- Kidney disease: Orlistat use has been associated with the formation of calcium oxalate kidney stones, particularly in patients with pre-existing chronic kidney disease. Maintaining adequate fluid intake is important.
- Thyroid conditions: If you take levothyroxine, orlistat may reduce its absorption. You may need to take levothyroxine and alli at different times of day, and thyroid function monitoring may be required.
- Epilepsy: There have been reports of changes in seizure frequency in patients taking anti-epileptic medications alongside orlistat. Discuss any changes with your doctor.
- HIV treatment: Orlistat may reduce the absorption of antiretroviral medications. If you are being treated for HIV, consult your healthcare team before starting alli.
alli must not be used by children or adolescents under 18 years of age. There is insufficient safety data in this population, and weight management in children should always be supervised by a paediatric specialist.
Pregnancy and Breastfeeding
Do not take alli if you are pregnant or breastfeeding. Weight loss during pregnancy is generally contraindicated because adequate nutrition is essential for foetal development. If you discover you are pregnant while taking alli, stop taking the capsules immediately and contact your doctor. Women of childbearing potential should note that severe diarrhoea associated with orlistat use may reduce the effectiveness of oral contraceptives; an additional barrier method of contraception is recommended if significant gastrointestinal symptoms occur.
How Does alli Interact with Other Drugs?
Quick Answer: alli has clinically significant interactions with ciclosporin, warfarin, levothyroxine, and oral contraceptives. It can reduce absorption of fat-soluble vitamins. Always tell your doctor about all medications you take before starting alli.
Because orlistat reduces fat absorption, it can also affect the absorption of fat-soluble medications and nutrients. Additionally, some drugs have specific pharmacokinetic interactions with orlistat that require dose adjustments or timing changes. The table below summarises the most important drug interactions.
Major Interactions (Do Not Combine)
| Drug | Interaction | Recommendation |
|---|---|---|
| Ciclosporin | Reduced ciclosporin blood levels, risk of transplant rejection | Do not use together. Contraindicated. |
| Warfarin / Anticoagulants | Altered vitamin K absorption may affect INR and increase bleeding risk | Do not use together. Contraindicated. |
Moderate Interactions (Use with Caution)
| Drug | Interaction | Recommendation |
|---|---|---|
| Levothyroxine | Reduced absorption of thyroid hormone; risk of hypothyroidism | Take at different times. Monitor thyroid function. |
| Amiodarone | Reduced absorption of amiodarone may decrease cardiac efficacy | Consult your cardiologist before combining. |
| Anti-epileptic drugs | Possible changes in seizure frequency and severity | Monitor closely. Report any seizure changes. |
| Oral contraceptives | Severe diarrhoea may reduce pill absorption and efficacy | Use additional barrier contraception if diarrhoea occurs. |
| Acarbose | Both affect nutrient absorption; combined use not studied | Not recommended. Consult your doctor. |
| HIV antiretrovirals | Possible reduced absorption of antiretroviral medications | Consult your HIV specialist before combining. |
| Antihypertensives | Weight loss may reduce blood pressure, potentially requiring dose adjustment | Monitor blood pressure regularly. Dose may need reduction. |
| Statins / Cholesterol drugs | Weight loss and reduced fat intake may affect lipid levels | Monitor cholesterol. Dose may need adjustment. |
Because alli reduces fat absorption, it also reduces absorption of fat-soluble vitamins A, D, E, and K. Take a daily multivitamin containing these vitamins at bedtime — at least 2 hours after your last dose of alli — to ensure adequate absorption.
What Is the Correct Dosage of alli?
Quick Answer: Take one 60 mg capsule three times a day, just before, during, or up to one hour after each main meal. Do not exceed 3 capsules daily. Skip the dose if a meal is missed or contains no fat.
Adults (18 years and older)
Standard Dosage
Dose: 1 capsule (60 mg) three times daily
Timing: Just before, during, or up to 1 hour after each main meal (breakfast, lunch, dinner)
Administration: Swallow whole with water
Maximum: 3 capsules (180 mg) per day
The capsules should be taken with meals that contain some fat. If you skip a meal, or if a meal does not contain any fat, you should not take a capsule — alli will have no effect without dietary fat to block. Conversely, eating a meal with too much fat while taking alli significantly increases the likelihood and severity of gastrointestinal side effects. This is why following a low-fat diet is critical to the success of the treatment.
Setting Calorie and Fat Goals
To maximise the effectiveness of alli, you should set daily calorie and per-meal fat targets. Your calorie goal should be approximately 500 calories below what your body needs to maintain your current weight. The following table provides general guidance:
| Daily Calorie Goal | Max Fat Per Meal | Max Fat From Snacks/Day |
|---|---|---|
| 1,200 kcal | 12 g | 3 g |
| 1,400 kcal | 15 g | 3 g |
| 1,600 kcal | 17 g | 3 g |
| 1,800 kcal | 19 g | 3 g |
Distribute your fat intake evenly across meals rather than saving your allowance for a single high-fat meal. This approach minimises gastrointestinal side effects and provides better weight loss results. Do not eat less than 1,200 calories per day, as this can lead to nutritional deficiencies.
Children and Adolescents
alli is not approved for use in children and adolescents under 18 years of age. Weight management in young people should be guided by a paediatric healthcare professional and typically involves behavioural and dietary interventions rather than medication.
Elderly
There are no specific dose adjustments for elderly patients. However, older adults should consult their doctor before starting alli, as they may be taking multiple medications and may have reduced kidney or liver function that affects drug safety. Adequate hydration and vitamin supplementation are particularly important in this group.
Missed Dose
If you forget to take a capsule:
- If less than 1 hour has passed since your last main meal, take the missed capsule.
- If more than 1 hour has passed, skip the missed dose and take your next capsule with your next main meal as usual.
- Do not take a double dose to make up for a missed one.
Overdose
Do not take more than 3 capsules per day. Single doses of 800 mg orlistat and multiple doses of up to 400 mg three times daily for 15 days have been studied in normal-weight and obese subjects without significant adverse findings. However, if you believe you have taken too many capsules, contact a healthcare professional or your local poison control centre immediately. Supportive care and monitoring for gastrointestinal symptoms are recommended.
Treatment Duration
alli should not be taken for longer than 6 months. If you have not achieved meaningful weight loss after 12 weeks of consistent use with diet and exercise, you should stop taking alli and consult your doctor or pharmacist. They can help you evaluate whether an alternative approach to weight management may be more appropriate. Successful long-term weight management requires sustained lifestyle changes — including permanent dietary improvements and regular physical activity — not just medication.
What Are the Side Effects of alli?
Quick Answer: The most common side effects are gastrointestinal, including oily or fatty stools, flatulence with oily discharge, urgent bowel movements, and soft stools. These are caused by the drug's fat-blocking mechanism and can be managed by following a low-fat diet.
Like all medicines, alli can cause side effects, although not everyone experiences them. The majority of side effects are related to the drug's mechanism of blocking fat absorption — when undigested fat passes through the intestine, it produces characteristic gastrointestinal symptoms. These effects are generally most pronounced during the first few weeks of treatment, before you have fully adjusted your dietary fat intake.
Very Common (affects more than 1 in 10 people)
These are directly caused by the fat-blocking mechanism
- Flatulence (gas) with or without oily discharge
- Urgent bowel movements
- Oily or fatty stools
- Soft stools
Common (affects up to 1 in 10 people)
Usually mild and manageable
- Abdominal pain or discomfort
- Faecal incontinence
- Liquid or watery stools
- More frequent bowel movements
- Anxiety
Serious Side Effects (frequency not known)
Stop taking alli and seek medical attention immediately
- Severe allergic reactions: difficulty breathing, sweating, rash, itching, facial swelling, rapid heartbeat, collapse
- Rectal bleeding
- Diverticulitis: lower abdominal pain (especially left side), fever, constipation
- Pancreatitis: severe stomach pain radiating to the back, fever, nausea, vomiting
- Skin blistering (including bullous eruptions)
- Gallstones: severe abdominal pain
- Hepatitis: yellowing of skin/eyes, dark urine, liver tenderness, itching
- Oxalate nephropathy: calcium oxalate build-up that may lead to kidney stones
The gastrointestinal effects of alli are a direct result of its mechanism of action and can be significantly reduced by following these practical tips:
- Start your low-fat diet a few days to one week before beginning alli to allow your body to adjust.
- Learn the fat content of your favourite foods and monitor portion sizes carefully.
- Spread your fat intake evenly across all three meals. Do not save your fat allowance for one large high-fat meal.
- If you experience no gastrointestinal effects, it does not mean the capsules are not working.
Effects Seen in Blood Tests
In some patients, blood tests may show elevated liver enzymes. If you are taking warfarin or other anticoagulants, orlistat may affect blood clotting parameters (INR). Always inform your doctor or laboratory that you are taking alli when having blood tests.
How Should You Store alli?
Quick Answer: Store alli below 25°C in the original container, tightly closed. Keep the silica gel desiccants inside the container. Do not use after the expiry date.
Proper storage of alli ensures the capsules remain effective throughout their shelf life. Follow these guidelines:
- Keep out of sight and reach of children.
- Do not use after the expiry date printed on the container and carton (after "EXP"). The expiry date refers to the last day of that month.
- Store at or below 25°C (77°F).
- Keep the container tightly closed, as the capsules are moisture-sensitive.
- The container includes two sealed desiccant canisters containing silica gel to keep the capsules dry. Leave these canisters inside the container. Do not swallow them.
- You can use the blue shuttle case (included in the pack) to carry your daily dose. Discard any capsules stored in the shuttle case for more than 1 month.
- Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer needed. These measures help protect the environment.
What Does alli Contain?
Quick Answer: Each capsule contains 60 mg of the active ingredient orlistat. The capsules are turquoise with a dark blue band, marked "alli".
Active Ingredient
Each hard capsule contains 60 mg orlistat.
Other Ingredients (Excipients)
The inactive ingredients ensure stability, capsule formation, and identification:
- Capsule contents: Microcrystalline cellulose (E460), sodium starch glycolate, povidone (E1201), sodium lauryl sulfate, talc.
- Capsule shell: Gelatin, indigo carmine (E132), titanium dioxide (E171), sodium lauryl sulfate, sorbitan monolaurate, black ink (shellac, black iron oxide (E172), propylene glycol).
- Capsule band: Gelatin, polysorbate 80, indigo carmine (E132).
Appearance and Pack Sizes
alli capsules have a turquoise shell with a dark blue band around the middle, printed with "alli". Available pack sizes include 42, 60, 84, 90, and 120 capsules. Not all pack sizes may be marketed in every country. A blue shuttle case is included for carrying your daily dose.
alli contains less than 1 mmol (23 mg) sodium per capsule, making it essentially sodium-free. This is important for patients on sodium-restricted diets.
BMI Eligibility Guide for alli
Quick Answer: alli is for adults with a BMI of 28 or higher. The table below shows the minimum weight required for each height to meet the BMI 28 threshold.
| Height | Minimum Weight |
|---|---|
| 150 cm (4'11") | 63 kg (139 lbs) |
| 155 cm (5'1") | 67.25 kg (148 lbs) |
| 160 cm (5'3") | 71.75 kg (158 lbs) |
| 165 cm (5'5") | 76.25 kg (168 lbs) |
| 170 cm (5'7") | 81 kg (179 lbs) |
| 175 cm (5'9") | 85.75 kg (189 lbs) |
| 180 cm (5'11") | 90.75 kg (200 lbs) |
| 185 cm (6'1") | 95.75 kg (211 lbs) |
| 190 cm (6'3") | 101 kg (223 lbs) |
If your weight is below the minimum listed for your height, you do not meet the BMI threshold for alli use. Consult a healthcare provider for personalised weight management advice.
Frequently Asked Questions About alli
alli contains orlistat, which works by blocking approximately 25% of the fat you eat from being absorbed by your body. The active ingredient inhibits gastrointestinal lipase enzymes that normally break down dietary fat into absorbable components. The undigested fat passes through your digestive system and is eliminated in your stool. alli must be used alongside a reduced-calorie, low-fat diet for best results. For every 2 kg you lose through dieting alone, alli can help you lose up to 1 additional kilogram.
Both alli and Xenical contain the same active ingredient, orlistat, but at different strengths. alli contains 60 mg of orlistat and is available over the counter (OTC) without a prescription in most countries. Xenical contains 120 mg of orlistat and typically requires a doctor's prescription. The higher-dose Xenical blocks slightly more fat absorption but may also produce more gastrointestinal side effects. The choice between them depends on your clinical situation and your doctor's recommendation.
Yes, because alli blocks fat absorption, it can also reduce the absorption of fat-soluble vitamins A, D, E, and K. To prevent deficiencies, you should take a daily multivitamin supplement containing these vitamins at bedtime, at least 2 hours after your last dose of alli. This timing ensures the vitamins are absorbed without interference from orlistat.
alli should generally not be taken for more than 6 months continuously. If you have not achieved meaningful weight loss after 12 weeks of consistent use alongside diet and exercise, consult your doctor or pharmacist for advice. Successful long-term weight management requires permanent lifestyle changes, including dietary improvements and regular physical activity, rather than ongoing medication use.
You should not take alli if you are pregnant or breastfeeding, taking ciclosporin (used after organ transplants), taking warfarin or other blood thinners, have cholestasis (blocked bile flow), have chronic malabsorption syndrome, or are allergic to orlistat or any of the capsule ingredients. alli is not suitable for anyone under 18 years of age. Always consult a healthcare provider before starting alli, especially if you have diabetes, kidney disease, thyroid conditions, epilepsy, or are taking HIV medications.
alli is not expected to affect your ability to drive or operate machinery. Orlistat acts locally in the gut with minimal systemic absorption, so it does not cause drowsiness, dizziness, or impaired concentration. However, if you experience any unexpected symptoms that affect your alertness, do not drive until you have consulted your healthcare provider.
References
All medical information in this article is based on peer-reviewed research, international guidelines, and regulatory agency data:
- European Medicines Agency (EMA). alli — Summary of Product Characteristics. EMA. Available at: ema.europa.eu/en/medicines/human/EPAR/alli
- Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155-161.
- National Institute for Health and Care Excellence (NICE). Obesity: identification, assessment and management. Clinical guideline [CG189]. 2014 (updated 2022).
- World Health Organization (WHO). Obesity and overweight fact sheet. 2024. Available at: who.int/news-room/fact-sheets/detail/obesity-and-overweight
- U.S. Food and Drug Administration (FDA). Orlistat (marketed as Alli and Xenical) Information. FDA Drug Safety Communication.
- Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335(7631):1194-1199.
- Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy. 2000;20(3):270-279.
- British National Formulary (BNF). Orlistat. NICE BNF. Available at: bnf.nice.org.uk
About Our Medical Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, which includes board-certified specialists in clinical pharmacology, internal medicine, and endocrinology. Our team follows the GRADE evidence framework and adheres to international guidelines from the WHO, EMA, FDA, NICE, and other regulatory bodies.
Evidence-Based Approach
All medical claims are supported by Level 1A evidence from systematic reviews and meta-analyses of randomised controlled trials where available. Sources include the Cochrane Library, BMJ, and major regulatory agencies.
Independent & Unbiased
iMedic receives no funding from pharmaceutical companies. All content is editorially independent and free from commercial influence. We have no conflict of interest in recommending or advising against any medication.